mRNA Therapies Show Promise in Treating Osteoarthritis

Strategic Insights -

Researchers at the University Medical Center Utrecht have made significant discoveries in the field of osteoarthritis treatment using mRNA therapies. The study, recently published in Acta Biomaterialia, investigates the use of poly(amidoamine)-based polymeric nanoparticles (PAA-based NPs) for mRNA delivery in joints. The findings suggest that PAA-based NPs are a promising platform for intra-articular mRNA delivery, with potential applications in osteoarthritis treatment.

Key Takeaways:

  • The study demonstrates that PAA-based NPs can effectively deliver mRNA to joint cells, including chondrocytes, in vitro and in vivo models simulating the complex joint environment.
  • The researchers found that positively charged uncoated NPs showed higher in vivo gene expression in OA knee joints than neutral PEG-coated NPs, while PEG-coated NPs induced more consistent gene expression in both healthy and OA knee joints.
  • The study highlights the potential of PAA-based NPs for osteoarthritis research, and the interplay between NP properties, joint biology, and disease state can affect mRNA delivery.
  • The findings suggest that mRNA therapies may be a promising disease-modifying treatment for osteoarthritis, and further research is needed to explore this potential.
  • The study was conducted in collaboration with researchers from the University Medical Center Utrecht, and the findings were published in Acta Biomaterialia, a peer-reviewed journal.

Statistics:

  • The study involved the use of four different models: 2D culture of chondrocytes, cartilage-on-chip platform, ex vivo culture of mouse knee joints, and in vivo OA rat model.
  • The researchers found that PEG-coated NPs showed favorable physicochemical properties and higher cell uptake in the 2D cell culture.
  • In the cartilage-on-chip platform, both uncoated and PEG-coated NPs displayed cartilage penetration and uptake by tissue-resident chondrocytes.
  • Upon intra-articular administration in vivo, the PAA-based NPs did not affect cartilage integrity in healthy nor OA rat knee joints, although enhanced synovial inflammation was observed.
  • The study showed that uncoated NPs showed prolonged retention compared to PEG-coated NPs and higher luciferase expression in OA knee joints than in healthy joints of rats.

Sources:

  • Rios, J. L., et al. (2025). In vitro and in vivo delivery of mRNA to joint cells using polymeric nanoparticles. Acta Biomaterialia, 2025.
  • Acta Biomaterialia can be contacted at: Elsevier Sci Ltd, 125 London Wall, London, England. (Elsevier - www.elsevier.com; Acta Biomaterialia - www.journals.elsevier.com/acta-biomaterialia/)
  • University Medical Center Utrecht, Dept. of Orthopedics, Heidelberglaan 100, 3584 CX Utrecht, Netherlands.